Search Results 371-380 of 16759 for Bioavailability

  1. Molecular Regulation of Muscle Glucose Metabolism - Mayo Clinic

    About this study. This protocol is being conducted to determine the mechanisms responsible for insulin resistance, obesity and type 2 diabetes.

  2. Use of Decision Aids in Clinical Encounters

    About this study. The active strategy for dissemination and implementation of Share Evidence Based Medicine (EBM) will yield greater reach of clinicians, ...

  3. Study of Tipifarnib in Subjects With Relapsed or Refractory Peripheral T-Cell Lymphoma - Mayo Clinic

    Tipifarnib will be administered until disease progression then followed approximately every 12 weeks for survival until either death or 12 months after accrual ...

  4. Cardiovascular Medicine - Clinical trials

    Bicuspid aortic valve (BAV) disease is the most frequent congenital cardiac malformation, occurring in 0.5-1.2% of the US population.

  5. A Study of the Safety and Effectiveness of Chronic Subcutaneous CD-NP for Renal Blood Vessel Protection for Patients who have Heart Failure and an LVAD - Mayo Clinic

    A Study of the Safety and Effectiveness of Chronic Subcutaneous CD-NP for Renal Blood Vessel Protection for Patients who have Heart Failure and an LVAD.

  6. Oncology (Medical) - Clinical trials

    Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

  7. A Study Using Momelotinib in Transfusion-Dependent Adults with Primary Myelofibrosis, Post-Polycythemia Vera or Post-Essential Thrombocythemia Myelofibrosis - Mayo Clinic

    A Study Using Momelotinib in Transfusion-Dependent Adults with Primary Myelofibrosis, Post-Polycythemia Vera or Post-Essential Thrombocythemia Myelofibrosis.

  8. A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia - Mayo Clinic

    The purpose of this study is to investigate the safety and tolerability of a single intravenous (IV) dose of SGT-501. Participation eligibility. Participant ...

  9. COVID and Diabetes Assessment - Clinical Trials

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. A Study of How Age Affects Osteoclast Inhibition and Bone Formation - Mayo Clinic

    This protocol addresses three main questions. How are gene expression changes in bone cells affected by aging? Is aging associated with decreased signaling ...